86 related articles for article (PubMed ID: 28190310)
21. [Establishment and verification of detecting multiple biomarkers for ovarian cancer by suspension array technology].
Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li DR; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Oct; 51(10):765-772. PubMed ID: 27788745
[No Abstract] [Full Text] [Related]
22. Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses.
Wang Q; Li D; Zhang W; Tang B; Li QQ; Li L
Int J Biol Markers; 2011; 26(4):262-73. PubMed ID: 21928244
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
24. A combined biomarker panel shows improved sensitivity and specificity for detection of ovarian cancer.
Mao L; Tang Y; Deng MJ; Huang CT; Lan D; Nong WZ; Li L; Wang Q
J Clin Lab Anal; 2022 Feb; 36(2):e24232. PubMed ID: 34995016
[TBL] [Abstract][Full Text] [Related]
25. [Screening and sero-immunoscreening of ovarian epithelial cancer associative antigens].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):834-9. PubMed ID: 18476518
[TBL] [Abstract][Full Text] [Related]
26. [Clinical validation of multiple biomarkers suspension array technology for ovarian cancer].
Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):11-19. PubMed ID: 28190310
[No Abstract] [Full Text] [Related]
27. The role of biomarkers in the management of epithelial ovarian cancer.
Yang WL; Lu Z; Bast RC
Expert Rev Mol Diagn; 2017 Jun; 17(6):577-591. PubMed ID: 28468520
[TBL] [Abstract][Full Text] [Related]
28. HE4 in the differential diagnosis of ovarian masses.
Granato T; Porpora MG; Longo F; Angeloni A; Manganaro L; Anastasi E
Clin Chim Acta; 2015 Jun; 446():147-55. PubMed ID: 25892674
[TBL] [Abstract][Full Text] [Related]
29. New tumor markers: CA125 and beyond.
Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; Liu J; Baggerly KA; Atkinson EN; Skates S; Zhang Z; Lokshin A; Menon U; Jacobs I; Lu K
Int J Gynecol Cancer; 2005; 15 Suppl 3():274-81. PubMed ID: 16343244
[TBL] [Abstract][Full Text] [Related]
30. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
Fortner RT; Damms-Machado A; Kaaks R
Gynecol Oncol; 2017 Nov; 147(2):465-480. PubMed ID: 28800944
[TBL] [Abstract][Full Text] [Related]
31. Review of biomarker systems as an alternative for early diagnosis of ovarian carcinoma.
Srivastava A; Gupta A; Patidar S
Clin Transl Oncol; 2021 Oct; 23(10):1967-1978. PubMed ID: 33840014
[TBL] [Abstract][Full Text] [Related]
32. Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection.
Berek JS; Bast RC
Cancer; 1995 Nov; 76(10 Suppl):2092-6. PubMed ID: 8635006
[TBL] [Abstract][Full Text] [Related]
33. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours.
Ain QU; Muhammad S; Hai Y; Peiling L
J Obstet Gynaecol; 2022 Nov; 42(8):3441-3449. PubMed ID: 36757337
[TBL] [Abstract][Full Text] [Related]
34. Early detection and screening for ovarian cancer.
Schwartz PE; Chambers JT; Taylor KJ
J Cell Biochem Suppl; 1995; 23():233-7. PubMed ID: 8747402
[TBL] [Abstract][Full Text] [Related]
35. Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.
Capriglione S; Luvero D; Plotti F; Terranova C; Montera R; Scaletta G; SchirĂ² T; Rossini G; Benedetti Panici P; Angioli R
Med Oncol; 2017 Aug; 34(9):164. PubMed ID: 28825178
[TBL] [Abstract][Full Text] [Related]
36. Early stage detection and screening of ovarian cancer: A research opportunity and significant challenge for biosensor technology.
Franier B; Thompson M
Biosens Bioelectron; 2019 Jun; 135():71-81. PubMed ID: 31003031
[TBL] [Abstract][Full Text] [Related]
37. Molecular Pathology of Ovarian Epithelial Neoplasms: Predictive, Prognostic, and Emerging Biomarkers.
Ordulu Z; Watkins J; Ritterhouse LL
Surg Pathol Clin; 2021 Sep; 14(3):415-428. PubMed ID: 34373093
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]